Steven Cohen's NVCR Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 900,496 shares of NovoCure Limited (NVCR) worth $11.64 M, representing 0.01% of the portfolio. First purchased in 2019-Q1, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in NVCR, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 783,896 shares. Largest reduction occurred in Q3 2025, reducing 353,400 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's NovoCure Limited (NVCR) Holding Value Over Time
Track share changes against reported price movement
Quarterly NovoCure Limited (NVCR) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +783,896 | Add 672.30% | 900,496 | $12.93 |
| Q3 2025 | -353,400 | Reduce 75.19% | 116,600 | $12.92 |
| Q2 2025 | +470,000 | New Buy | 470,000 | $17.80 |
| Q2 2024 | -32,600 | Sold Out | 0 | $0.00 |
| Q1 2024 | -335,800 | Reduce 91.15% | 32,600 | $15.63 |
| Q4 2023 | +356,856 | Add 3091.27% | 368,400 | $14.93 |
| Q3 2023 | -13,289 | Reduce 53.51% | 11,544 | $16.15 |
| Q2 2023 | +24,833 | New Buy | 24,833 | $41.50 |
| Q3 2019 | -8,126 | Sold Out | 0 | $0.00 |
| Q2 2019 | -437 | Reduce 5.10% | 8,126 | $63.25 |
| Q1 2019 | +8,563 | New Buy | 8,563 | $48.11 |
Steven Cohen's NovoCure Limited Investment FAQs
Steven Cohen first purchased NovoCure Limited (NVCR) in Q1 2019, acquiring 8,563 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held NovoCure Limited (NVCR) for 11 quarters since Q1 2019.
Steven Cohen's largest addition to NovoCure Limited (NVCR) was in Q4 2025, adding 900,496 shares worth $11.64 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 900,496 shares of NovoCure Limited (NVCR), valued at approximately $11.64 M.
As of the Q4 2025 filing, NovoCure Limited (NVCR) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in NovoCure Limited (NVCR) was 900,496 shares, as reported at the end of Q4 2025.